🇺🇸 FDA
Patent

US 11672771

Beta-alethine, immune modulators, and uses thereof

granted A61KA61K31/16A61K38/177

Quick answer

US patent 11672771 (Beta-alethine, immune modulators, and uses thereof) held by AxImmune, Inc. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AxImmune, Inc.
Grant date
Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/16, A61K38/177, A61K38/2013, A61K39/00